Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Cancer Research|October 5, 2006
Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cellsYoshiyuki Saito, Isao Tachibana, Yoshito Takeda, et al.
Cell Reports|November 4, 2015
Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B CellsJianbo Sun, Jiguang Wang, Evangelos Pefanis, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2012
CXCL12 as a biological marker for the diagnosis of tuberculous pleurisySatoshi Kohmo, Takashi Kijima, Masahide Mori, et al.
Medicine|February 9, 2017
Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case ReportsTaro Koba, Takashi Kijima, Takayuki Takimoto, et al.
Scientific Reports|March 25, 2021
Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survivalDaisuke Katayama, Masahiro Yanagawa, Keiko Matsunaga, et al.
Oncology Research|January 17, 2008
Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case reportTakashi Kijima, Mayumi Suzuki, Kayo Ueda, et al.
FEBS Letters|October 8, 2016
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas databaseMasayoshi Higashiguchi, Izumi Nagatomo, Takashi Kijima, et al.
Molecular Cancer Therapeutics|March 6, 2012
HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancerToshiyuki Minami, Takashi Kijima, Yasushi Otani, et al.
Cancer Science|July 20, 2011
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancerTakashi Kijima, Kengo Takeuchi, Satoshi Tetsumoto, et al.
Scientific Reports|May 23, 2023
Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIsMari Tone, Kota Iwahori, Takayuki Shiroyama, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Cancer Research|October 5, 2006
Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cellsYoshiyuki Saito, Isao Tachibana, Yoshito Takeda, et al.
Cell Reports|November 4, 2015
Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B CellsJianbo Sun, Jiguang Wang, Evangelos Pefanis, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2012
CXCL12 as a biological marker for the diagnosis of tuberculous pleurisySatoshi Kohmo, Takashi Kijima, Masahide Mori, et al.
Medicine|February 9, 2017
Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case ReportsTaro Koba, Takashi Kijima, Takayuki Takimoto, et al.
Scientific Reports|March 25, 2021
Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survivalDaisuke Katayama, Masahiro Yanagawa, Keiko Matsunaga, et al.
Oncology Research|January 17, 2008
Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case reportTakashi Kijima, Mayumi Suzuki, Kayo Ueda, et al.
FEBS Letters|October 8, 2016
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas databaseMasayoshi Higashiguchi, Izumi Nagatomo, Takashi Kijima, et al.
Molecular Cancer Therapeutics|March 6, 2012
HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancerToshiyuki Minami, Takashi Kijima, Yasushi Otani, et al.
Cancer Science|July 20, 2011
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancerTakashi Kijima, Kengo Takeuchi, Satoshi Tetsumoto, et al.
Scientific Reports|May 23, 2023
Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIsMari Tone, Kota Iwahori, Takayuki Shiroyama, et al.
Pageof 15